1-20 of 28
Frank L. Meyskens
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2399: System analysis of adapted and quiescent/dormancy(QD) models of drug resistance in melanoma cell lines

Feng Liu, Parvita Paresh Panchal, Zi Wang, Ahmed Farhat, Angela Garcia, Tcharles Fagundes, Fabian Filipp, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 2399.
https://doi.org/10.1158/1538-7445.AM2016-2399
Published: 15 July 2016
View article titled, Abstract 2399: System analysis of adapted and quiescent/dormancy(QD) models of drug resistance in melanoma cell lines
Journal Articles

Abstract 14: A switch in metabolic phenotype in vemurafenib-resistant melanoma cells to increased amino acid dependence serves as an alternate mechanism for survival

Deeba N. Syed, Rahul K. Lall, Yong Wei Soon, Ahmed Aljohani, Changan Guo, Feng Liu, Frank L. Meyskens, James M. Ntambi, Hasan Mukhtar
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 14.
https://doi.org/10.1158/1538-7445.AM2016-14
Published: 15 July 2016
View article titled, Abstract 14: A switch in metabolic phenotype in vemurafenib-resistant melanoma cells to increased amino acid dependence serves as an alternate mechanism for survival
Journal Articles

Abstract 4744: Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma

SUN YANG, Zhen Yang, Richard B. Silverman, Thomas Poulos, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4744.
https://doi.org/10.1158/1538-7445.AM2016-4744
Published: 15 July 2016
View article titled, Abstract 4744: Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma
Journal Articles

Abstract 1179: Unique metabolic profile of Vemurafenib-resistant melanoma cells: a quantitative proteomics approach

Deeba N. Syed, Rahul K. Lall, Iram Majeed, Feng Liu, Frank L. Meyskens, Hasan Mukhtar
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1179.
https://doi.org/10.1158/1538-7445.AM2015-1179
Published: 01 August 2015
View article titled, Abstract 1179: Unique metabolic profile of Vemurafenib-resistant melanoma cells: a quantitative proteomics approach
Journal Articles

Abstract 3247: SAMe versus placebo for the reduction of serum AFP in patients with hepatitis C cirrhosis and moderately elevated AFP: A randomized, placebo-controlled, double-blind phase II trial

Timothy Morgan, Frank L. Meyskens, John Hoefs, Ke-Qin Hu, Tarek Hassanein, Thomas D. Boyer, Neville R. Pimstone, Kathy Osann, Rachel Gonzalez, L M. Rodriguez
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3247.
https://doi.org/10.1158/1538-7445.AM2014-3247
Published: 01 October 2014
View article titled, Abstract 3247: SAMe versus placebo for the reduction of serum AFP in patients with hepatitis C cirrhosis and moderately elevated AFP: A randomized, placebo-controlled, double-blind phase II trial
Journal Articles

Abstract SY26-02: SWOG S0701 phase III randomized trial of three antibiotic regimens to eradicate helicobacter pylori: efficacy and failure at one year

Laurence H. Baker, John J. Crowley, Manuel Valdivieso, Ricardo L. Dominguez, Luis E. Bravo, Rodolfo Pena, Maria M. Meza-Montenegro, Pelayo Correa, William D. Chey, Douglas R. Morgan, Frank L. Meyskens, Gary E. Goodman
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): SY26-02.
https://doi.org/10.1158/1538-7445.AM2012-SY26-02
Published: 15 April 2012
View article titled, Abstract SY26-02: SWOG S0701 phase III randomized trial of three antibiotic regimens to eradicate helicobacter pylori: efficacy and failure at one year
Journal Articles

Abstract 1937: APE/Ref-1, a drugable target for the therapy of human melanoma

Sun Yang, Zhonghui Zheng, Bobbye Misner, Richard Chamberlin, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1937.
https://doi.org/10.1158/1538-7445.AM2012-1937
Published: 15 April 2012
View article titled, Abstract 1937: APE/Ref-1, a drugable target for the therapy of human melanoma
Journal Articles

Abstract 268: Regulation of the UDP-glucuronosyltransferases (UGTs) by UV exposure in human melanocytes

Ryan W. Dellinger, Amelia S. Ahmed, Priscilla H. Duong, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 268.
https://doi.org/10.1158/1538-7445.AM2012-268
Published: 15 April 2012
View article titled, Abstract 268: Regulation of the UDP-glucuronosyltransferases (UGTs) by UV exposure in human melanocytes
Journal Articles

Abstract 5466: nNOS, a novel target for melanoma prevention and therapy

Sun Yang, Zhen Yang, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5466.
https://doi.org/10.1158/1538-7445.AM10-5466
Published: 15 April 2010
View article titled, Abstract 5466: nNOS, a novel target for melanoma prevention and therapy
Journal Articles

Abstract 2553: Characterization of the UDP-Glucuronosyltransferases in melanocytes and melanoma

Ryan W. Dellinger, Harry H. Matundan, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2553.
https://doi.org/10.1158/1538-7445.AM10-2553
Published: 15 April 2010
View article titled, Abstract 2553: Characterization of the UDP-Glucuronosyltransferases in melanocytes and melanoma
Journal Articles

Abstract LB-142: Marked efficacy of difluoromethylornithine plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled, double-blind Phase III trial.

Frank L. Meyskens, Jr., Eugene W Gerner, Daniel Pelot, Philip M Carpenter, Christine E. McLaren, Sharon Fujikawa-Brooks, Michael Lawson, Jayashri Kidao, John McCracken, Gregory Albers, Dennis J Ahnen, Kim Turgeon
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-142.
https://doi.org/10.1158/1538-7445.AM2008-LB-142
Published: 15 May 2008
View article titled, Abstract LB-142: Marked efficacy of difluoromethylornithine plus sulindac in reducing recurrent colorectal adenomas in patients with prior adenomas: Results of a randomized, placebo-controlled, double-blind Phase III trial.
Journal Articles

Response of Rosiglitazone, UAB 30, and SR 13668 in the human melanoma prevention assay

Eugene Elmore, Aarti Jain, Levy Kopelovitch, Frank L. Meyskens, Vernon E. Steele, J. Leslie Redpath
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1129.
Published: 15 April 2006
View article titled, Response of Rosiglitazone, UAB 30, and SR 13668 in the human melanoma prevention assay
Journal Articles

A potential mitochondrial survival mechanism in human metastatic melanoma cells

Ravi S. Kahlon, Sun Yang, Julie A. Buckmeier, Nilou B. Tohidian, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1103–1104.
Published: 15 April 2006
View article titled, A potential mitochondrial survival mechanism in human metastatic melanoma cells
Journal Articles

Expression of apurinic/apyrymidinic endonuclease/redox effector-1 (APE/Ref-1) is elevated with progression of human melanoma and the therapeutic potential of APE/Ref-1 inhibitors

Sun Yang, Kaikobad Irani, Sookhee Chun, Frank L. Meyskens
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1043.
Published: 01 May 2005
View article titled, Expression of apurinic/apyrymidinic endonuclease/redox effector-1 (APE/Ref-1) is elevated with progression of human melanoma and the therapeutic potential of APE/Ref-1 inhibitors
Journal Articles

Possible contribution of copper to UVB induced carcinogenesis in melanocytes by amplifying oxidative effect of UVB on melanosomes

Shirley Gidanian, Frank L. Meyskens, Jr
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1125.
Published: 01 May 2005
View article titled, Possible contribution of copper to UVB induced carcinogenesis in melanocytes by amplifying oxidative effect of UVB on melanosomes
Journal Articles

Ki-ras Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study

Dennis J. Ahnen, Polly Feigl, Gang Quan, Cecelia Fenoglio-Preiser, Laura C. Lovato, Paul A. Bunn, Jr., Grant Stemmerman, John D. Wells, John S. Macdonald, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1998) 58 (6): 1149–1158.
Published: 01 March 1998
View article titled, Ki-<em>ras</em> Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study
Open the PDF for Ki-<em>ras</em> Mutation and p53 Overexpression Predict the Clinical Behavior of Colorectal Cancer: A Southwest Oncology Group Study in another window
Journal Articles

Differences in Basic Fibroblast Growth Factor RNA and Protein Levels in Human Primary Melanocytes and Metastatic Melanoma Cells

Douglas T. Yamanishi, Mark J. Graham, Robert Z. Florkiewicz, Julie A. Buckmeier, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1992) 52 (18): 5024–5029.
Published: 01 September 1992
View article titled, Differences in Basic Fibroblast Growth Factor RNA and Protein Levels in Human Primary Melanocytes and Metastatic Melanoma Cells
Open the PDF for Differences in Basic Fibroblast Growth Factor RNA and Protein Levels in Human Primary Melanocytes and Metastatic Melanoma Cells in another window
Journal Articles

Identification of a Recurring Translocation Site Involving Chromosome 6 in Human Malignant Melanoma

Jeffrey M. Trent, Floyd H. Thompson, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1989) 49 (2): 420–423.
Published: 01 January 1989
View article titled, Identification of a Recurring Translocation Site Involving Chromosome 6 in Human Malignant Melanoma
Open the PDF for Identification of a Recurring Translocation Site Involving Chromosome 6 in Human Malignant Melanoma in another window
Journal Articles

Rationale and Strategies for Chemoprevention of Cancer in Humans

John S. Bertram, Laurence N. Kolonel, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1987) 47 (11): 3012–3031.
Published: 01 June 1987
View article titled, Rationale and Strategies for Chemoprevention of Cancer in Humans
Open the PDF for Rationale and Strategies for Chemoprevention of Cancer in Humans in another window
Journal Articles

Stimulation of Human Metastatic Melanoma Colony-forming Cells by an Acid-sensitive Factor in Human Platelet Sonicate

Nancy J. Sipes, Marvin D. Bregman, Frank L. Meyskens, Jr.
Journal: Cancer Research
Cancer Res (1985) 45 (12_Part_1): 6268–6272.
Published: 01 December 1985
View article titled, Stimulation of Human Metastatic Melanoma Colony-forming Cells by an Acid-sensitive Factor in Human Platelet Sonicate
Open the PDF for Stimulation of Human Metastatic Melanoma Colony-forming Cells by an Acid-sensitive Factor in Human Platelet Sonicate in another window